GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

alemtuzumab   Click here for help

GtoPdb Ligand ID: 6770

Synonyms: campath 1H | Campath® | campath-1H | Lemtrada®
Approved drug Immunopharmacology Ligand
alemtuzumab is an approved drug (FDA (2001), EMA (2013))
Compound class: Antibody
Comment: CAMPATH-1 (CD52) antigen inhibitor. Functionally, alemtuzumab causes depletion and then recovery of the immune system.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: alemtuzumab

Classification Click here for help
Compound class Antibody
Approved drug? Yes. US FDA (2001)  |  EU EMA (2013)
International Nonproprietary Names Click here for help
INN number INN
8005 alemtuzumab
Synonyms Click here for help
campath 1H | Campath® | campath-1H | Lemtrada®
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 11
Other databases
GtoPdb PubChem SID 178103376
PubChem SID 178103376
Search PubMed clinical trials alemtuzumab
Search PubMed titles alemtuzumab
Search PubMed titles/abstracts alemtuzumab
Wikipedia Alemtuzumab